Zobrazeno 1 - 10 of 180 pro vyhledávání: '"Lourenco LM"'
1
Report
A multicenter case series documenting Medicare Part D plan denials of immunosuppressant drug coverage for organ transplant recipients.
Autor: Lushin EN; Department of Pharmacy, Indiana University Health, Indianapolis, Indiana., McDermott JK; Department of Pharmacy, Spectrum Health, Grand Rapids, Michigan., Truax C; Department of Pharmacy, University of Utah Health, Salt Lake City, Utah., Lourenco LM; Department of Pharmacy Services, University of Chicago Medicine, Chicago, Illinois., Mariski M; Department of Pharmacy, University of California San Diego Health, San Diego, California., Melaragno JI; Department of Pharmacy, University of Rochester Medical Center, Rochester, New York., Potter LM; Department of Pharmacy Services, University of Chicago Medicine, Chicago, Illinois.
Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Feb; Vol. 21 (2), pp. 889-896. Date of Electronic Publication: 2020 Oct 17.
Zobrazit plný text záznamu
2
Akademický článek
The Clinical Conundrum of Cannabis: Current Practices and Recommendations for Transplant Clinicians: An Opinion of the Immunology/Transplantation PRN of the American College of Clinical Pharmacy.
Autor: Melaragno JI; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY., Bowman LJ; Department of Pharmacy, Tampa General Hospital, Tampa, FL., Park JM; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI., Lourenco LM; Department of Pharmacy Services, University of Chicago Medicine, Chicago, IL., Doligalski CT; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC., Brady BL; Department of Pharmacy, Indiana University Health University Hospital, Indianapolis, IN., Descourouez JL; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI., Chandran MM; Department of Pharmacy, Children's Hospital Colorado, Aurora, CO., Nickels MW; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY., Page RL 2nd; Department of Clinical Pharmacy, University of Colorado, Aurora, CO.
Publikováno v: Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 291-299.
Zobrazit plný text záznamu
3
Akademický článek
Implications for body weight extremes in solid organ transplantation.
Autor: Campara M; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, 60612, USA., Lourenco LM; University of Chicago, Chicago, IL, USA., Melaragno JI; University of Rochester Medical Center, Rochester, NY, USA., Kaiser TE; University of Cincinnati, Cincinnati, OH, USA.
Publikováno v: Pharmacotherapy [Pharmacotherapy] 2021 Jan; Vol. 41 (1), pp. 44-58. Date of Electronic Publication: 2021 Jan 19.
Zobrazit plný text záznamu
4
Akademický článek
Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy.
Autor: Willoughby CE; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Jiang Y; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Thomas HD; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Willmore E; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Kyle S; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Wittner A; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Phillips N; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Zhao Y; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Tudhope SJ; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Prendergast L; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Junge G; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Lourenco LM; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Finlay MRV; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Turner P; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Munck JM; Astex Pharmaceuticals, Cambridge, United Kingdom., Griffin RJ; Cancer Research UK Newcastle Drug Discovery Unit, Chemistry, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Rennison T; Cancer Research UK Newcastle Drug Discovery Unit, Chemistry, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Pickles J; Cancer Research UK Newcastle Drug Discovery Unit, Chemistry, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Cano C; Cancer Research UK Newcastle Drug Discovery Unit, Chemistry, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Newell DR; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Reeves HL; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Hepatopancreatobiliary Multidisciplinary Team, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Ryan AJ; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Wedge SR; Cancer Research UK Newcastle Drug Discovery Unit, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Publikováno v: The Journal of clinical investigation [J Clin Invest] 2020 Jan 02; Vol. 130 (1), pp. 258-271.
Zobrazit plný text záznamu
5
Akademický článek
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
Autor: Mumin NH; Department of Oncology, University of Oxford, Oxford, UK., Drobnitzky N; Department of Oncology, University of Oxford, Oxford, UK., Patel A; Department of Oncology, University of Oxford, Oxford, UK., Lourenco LM; Department of Oncology, University of Oxford, Oxford, UK., Cahill FF; Department of Oncology, University of Oxford, Oxford, UK., Jiang Y; Department of Oncology, University of Oxford, Oxford, UK., Kong A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ryan AJ; Department of Oncology, University of Oxford, Oxford, UK. anderson.ryan@oncology.ox.ac.uk.
Publikováno v: BMC cancer [BMC Cancer] 2019 Jan 24; Vol. 19 (1), pp. 102. Date of Electronic Publication: 2019 Jan 24.
Zobrazit plný text záznamu
6
Akademický článek
PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice.
Autor: Lourenco LM; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Jiang Y; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Drobnitzky N; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Green M; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Cahill F; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Patel A; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Shanneik Y; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Moore J; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Ryan AJ; Cancer Research UK and UK Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK. Electronic address: anderson.ryan@oncology.ox.ac.uk.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Mar 01; Vol. 100 (3), pp. 767-775. Date of Electronic Publication: 2017 Nov 06.
Zobrazit plný text záznamu
7
Akademický článek
Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool?
Autor: Grinstein J; University of Chicago Medical Center, Chicago, Illinois; Department of Medicine, Chicago, Illinois., Lourenco LM; University of Chicago Medical Center, Chicago, Illinois; Department of Medicine, Chicago, Illinois., Te HS; University of Chicago Medical Center, Chicago, Illinois; Department of Medicine, Chicago, Illinois., Renz JF; University of Chicago Medical Center, Chicago, Illinois; Department of Surgery, Chicago, Illinois., Jeevanandam V; University of Chicago Medical Center, Chicago, Illinois; Department of Surgery, Chicago, Illinois., Uriel N; University of Chicago Medical Center, Chicago, Illinois; Department of Medicine, Chicago, Illinois. Electronic address: nuriel@medicine.bsd.uchicago.edu.
Publikováno v: Journal of cardiac failure [J Card Fail] 2017 Oct; Vol. 23 (10), pp. 762-764. Date of Electronic Publication: 2017 Jun 13.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje